Vancomycin-resistant Enterococcus colonization in the intensive care unit: Clinical outcomes and attributable costs of hospitalization

The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients c...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of infection control Vol. 42; no. 10; pp. 1062 - 1066
Main Authors Jung, Euihan, Byun, Sookjin, Lee, Hojin, Moon, Sang Yi, Lee, Hyuck
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.10.2014
Elsevier
Mosby-Year Book, Inc
Subjects
Online AccessGet full text
ISSN0196-6553
1527-3296
1527-3296
DOI10.1016/j.ajic.2014.06.024

Cover

Loading…
Abstract The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
AbstractList The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017). Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
Background The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population. Methods We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization. Results During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P  = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P  = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P  = .038), ICU length of stay (OR, 1.93; P  < .001), ICU type (OR, 1.51; P  = .001), valvular heart disease (OR, 2.38; P  = .27), hospitalization within 12 months (OR, 1.21; P  = .037), and use of invasive devices (OR, 1.28; P  = .017). Conclusion Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population.BACKGROUNDThe clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting hospitalization length of stay (LOS) and costs. This study aimed to estimate mortality, LOS, and hospitalization costs for VRE colonized patients compared with a matched hospital population.We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization.METHODSWe performed a retrospective propensity score matched cohort study comparing the outcomes of patients with VRE colonization with those of uncolonized subjects matched at the time they were admitted to the intensive care unit (ICU). Between January 2008 and December 2010, we obtained rectal swab cultures within 24 hours of ICU admission to detect VRE colonization.During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017).RESULTSDuring the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. There were 199 VRE colonized patients compared with 199 uncolonized patients using the propensity score. VRE colonized patients when compared with uncolonized patients were likely to have a higher case fatality rate (24.6% vs 17.1%; OR, 2.35). Longer total admission days were observed in the VRE colonized patients (28.7 vs 21.4 days; multiplicative effect, 1.25; P = .004). VRE colonization is found to be a significant factor associated with increased ICU cost in the multivariable regression model ($6,065 vs $5,298; multiplicative effect, 1.22; P = .029). Multivariable analysis identified the factors affecting ICU cost as follows: VRE colonization (odds ratio [OR], 1.20; P = .038), ICU length of stay (OR, 1.93; P < .001), ICU type (OR, 1.51; P = .001), valvular heart disease (OR, 2.38; P = .27), hospitalization within 12 months (OR, 1.21; P = .037), and use of invasive devices (OR, 1.28; P = .017).Compared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.CONCLUSIONCompared with a matched hospital population, VRE colonization was associated with increased mortality, LOS, and costs. Strict infection control programs, including preemptive isolation for a high-risk group, should be helpful.
Author Byun, Sookjin
Lee, Hojin
Lee, Hyuck
Moon, Sang Yi
Jung, Euihan
Author_xml – sequence: 1
  givenname: Euihan
  orcidid: 0000-0002-8515-4927
  surname: Jung
  fullname: Jung, Euihan
  organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea
– sequence: 2
  givenname: Sookjin
  surname: Byun
  fullname: Byun, Sookjin
  organization: Infection Control Office, Dong-A University Hospital, Busan, Korea
– sequence: 3
  givenname: Hojin
  surname: Lee
  fullname: Lee, Hojin
  organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea
– sequence: 4
  givenname: Sang Yi
  surname: Moon
  fullname: Moon, Sang Yi
  organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea
– sequence: 5
  givenname: Hyuck
  orcidid: 0000-0002-4115-0748
  surname: Lee
  fullname: Lee, Hyuck
  email: hleeid@dau.ac.kr
  organization: Division of Infectious Diseases, Department of Internal Medicine, Dong-A University Hospital, Busan, Korea
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28886891$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/25278394$$D View this record in MEDLINE/PubMed
BookMark eNqFkktr3DAUhUVJaSZp_0AXRVAK2Xiqh6WxQymUIX1AoIs-tkKWrolcjzSV5MD0B_R3R2YmBAaari6I7xxdzrln6MQHDwi9pGRJCZVvh6UenFkyQuslkUvC6idoQQVbVZy18gQtCG1lJYXgp-gspYEQ0nIpnqFTVqCGt_UC_f2pvQmbnXG-ipBcytpnfOUzxGCCMVPCJozBuz86u-Cx8zjfQBkZfHK3gI2OgCfv8iVej847o0ccplw8IWHtLdY5R9dNWXdjoUPKCYce34S0dVmPB9_n6GmvxwQvDvMc_fh49X39ubr--unL-sN1ZQQjueIN6c1KaCs6axvKy2NrNeWsszWXK65ltxJWStt1fddw3dadrAlQJmrbakb5ObrY-25j-D1BymrjkoFx1B7ClBQVjaREFLKgr4_QIUzRl-0UlZRKQUXdFurVgZq6DVi1jW6j407dJ1yANwdAp5JNH0veLj1wTdPIpp03a_aciSGlCL0yJZ85mxy1GxUlai5dDWouXc2lKyJVKb1I2ZH03v1R0bu9CErctw6iSsaBN2BdBJOVDe5x-fsjuTm0_wt2kB6iUokpor7NpzhfIq3nI2xJMbj8t8H_fr8DjKPvYQ
CitedBy_id crossref_primary_10_1186_s13099_018_0259_4
crossref_primary_10_1186_s13613_021_00976_5
crossref_primary_10_1016_j_jgar_2019_06_022
crossref_primary_10_1016_j_surg_2025_109152
crossref_primary_10_1017_ice_2017_248
crossref_primary_10_1080_19490976_2024_2351478
crossref_primary_10_1007_s00103_018_2811_2
crossref_primary_10_1016_j_jhin_2018_02_016
crossref_primary_10_1016_j_diagmicrobio_2017_08_009
crossref_primary_10_1016_j_infpip_2024_100413
crossref_primary_10_1017_ash_2021_215
crossref_primary_10_3389_fimmu_2017_01890
crossref_primary_10_1186_s12879_021_06386_z
crossref_primary_10_1186_s13756_022_01081_3
crossref_primary_10_1111_tid_13821
crossref_primary_10_1186_s13756_017_0291_z
crossref_primary_10_1016_j_jhin_2018_07_018
crossref_primary_10_1177_1073274818794162
crossref_primary_10_1007_s00134_018_5268_8
crossref_primary_10_1186_s12879_023_08238_4
crossref_primary_10_1093_ofid_ofw133
crossref_primary_10_1097_BOT_0000000000000750
crossref_primary_10_3390_nu11123002
crossref_primary_10_3947_ic_2016_48_3_174
crossref_primary_10_1093_ejcts_ezv453
crossref_primary_10_1111_cbdd_13569
crossref_primary_10_1016_j_nmni_2021_100881
crossref_primary_10_1016_j_molmed_2019_04_011
crossref_primary_10_1186_2197_425X_3_S1_A124
crossref_primary_10_1016_j_amjms_2018_08_015
crossref_primary_10_1016_j_ajic_2015_11_026
crossref_primary_10_2807_1560_7917_ES_2022_27_5_2001660
crossref_primary_10_1186_s13756_019_0590_7
crossref_primary_10_1186_s13054_019_2488_4
crossref_primary_10_1186_s12913_018_3549_0
crossref_primary_10_1007_s10096_015_2436_4
crossref_primary_10_5392_JKCA_2015_15_06_346
Cites_doi 10.1001/archinte.165.3.302
10.1056/NEJM200003093421007
10.7883/yoken.65.57
10.2307/30141777
10.1016/S0140-6736(88)91037-9
10.1056/NEJMoa1000373
10.1016/j.ajic.2006.04.205
10.1001/archinte.162.19.2223
10.1001/archinte.158.10.1127
10.1016/j.ajic.2012.01.009
10.1016/j.ijantimicag.2003.12.019
10.1016/j.ajic.2012.04.331
10.1164/ajrccm.160.3.9808145
10.1016/j.ajic.2008.09.025
10.4040/jkan.2013.43.2.287
10.1016/j.ijid.2012.09.019
10.1086/502213
10.1086/512261
10.2307/2532206
10.1086/524331
ContentType Journal Article
Copyright 2014 Association for Professionals in Infection Control and Epidemiology, Inc.
Association for Professionals in Infection Control and Epidemiology, Inc.
2015 INIST-CNRS
Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Copyright Mosby-Year Book, Inc. Oct 2014
Copyright_xml – notice: 2014 Association for Professionals in Infection Control and Epidemiology, Inc.
– notice: Association for Professionals in Infection Control and Epidemiology, Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Mosby-Year Book, Inc. Oct 2014
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ajic.2014.06.024
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1527-3296
EndPage 1066
ExternalDocumentID 3460960141
25278394
28886891
10_1016_j_ajic_2014_06_024
S0196655314009390
1_s2_0_S0196655314009390
Genre Journal Article
Observational Study
Feature
GroupedDBID ---
--K
--M
..I
.1-
.FO
.GJ
.~1
0-6
0R~
1B1
1P~
1RT
1Z5
1~.
1~5
23M
2KS
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AAAJQ
AABNK
AABSN
AAEDT
AAEDW
AAIKC
AAIKJ
AAKOC
AALRI
AAMNW
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACJTP
ACRLP
ACRPL
ACVFH
ACXZT
ADBBV
ADCNI
ADEZE
ADIMB
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXBA
AFXIZ
AGBRE
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BEEDS
BKOJK
BLXMC
BNPGV
C45
CAG
CJTIS
COF
COPKO
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FAFAN
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
H~W
IH2
IHE
J1W
J5H
K-O
KOM
L7B
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OD-
OEN
OMK
ONC
ONOOK
OO.
OUGNH
OVD
OZT
P-8
P-9
PC.
PQQKQ
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SNC
SND
SNG
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UHS
UV1
WH7
WOQ
WOW
WUQ
XCE
YFH
YOC
Z5R
ZGI
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AISVY
AJBFU
EFLBG
LCYCR
NAHTW
ZA5
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c520t-380fc75ad5bdd8135209da132bd43673a6b75d66dbbfb83a94b640e1254d9a213
IEDL.DBID .~1
ISSN 0196-6553
1527-3296
IngestDate Thu Jul 10 22:10:25 EDT 2025
Sun Jul 13 04:23:07 EDT 2025
Mon Jul 21 06:01:28 EDT 2025
Wed Apr 02 07:16:15 EDT 2025
Tue Jul 01 01:59:36 EDT 2025
Thu Apr 24 22:53:09 EDT 2025
Fri Feb 23 02:32:48 EST 2024
Sun Feb 23 10:19:18 EST 2025
Tue Aug 26 16:32:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Enterococcus
Intensive care units
Vancomycin resistance
Infection control
Costs
Prognosis
Check
Hospitalization
Intensive care unit
Prevention
Infection
Streptococcaceae
Health economy
Bacteria
Micrococcales
Public health
Colonization
Language English
License CC BY 4.0
Copyright © 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c520t-380fc75ad5bdd8135209da132bd43673a6b75d66dbbfb83a94b640e1254d9a213
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-8515-4927
0000-0002-4115-0748
PMID 25278394
PQID 1611651549
PQPubID 105487
PageCount 5
ParticipantIDs proquest_miscellaneous_1586105213
proquest_journals_1611651549
pubmed_primary_25278394
pascalfrancis_primary_28886891
crossref_citationtrail_10_1016_j_ajic_2014_06_024
crossref_primary_10_1016_j_ajic_2014_06_024
elsevier_sciencedirect_doi_10_1016_j_ajic_2014_06_024
elsevier_clinicalkeyesjournals_1_s2_0_S0196655314009390
elsevier_clinicalkey_doi_10_1016_j_ajic_2014_06_024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-10-01
PublicationDateYYYYMMDD 2014-10-01
PublicationDate_xml – month: 10
  year: 2014
  text: 2014-10-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: St. Louis
PublicationTitle American journal of infection control
PublicationTitleAlternate Am J Infect Control
PublicationYear 2014
Publisher Elsevier Inc
Elsevier
Mosby-Year Book, Inc
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Mosby-Year Book, Inc
References Parsons (bib8) 2000
Greenland, Drescher (bib9) 1993; 49
Huskins, Huckabee, O'Grady, Murray, Kopetskie, Zimmer (bib22) 2011; 364
Muto, Jernigan, Ostrowsky, Richet, Jarvis, Boyce (bib19) 2003; 24
Carmeli, Eliopoulos, Mozaffari, Samore (bib15) 2002; 162
Kim, Kim, Kim, Lee, Park, Kang (bib13) 2012; 40
Duckro, Blom, Lyle, Weinstein, Hayden (bib21) 2005; 165
Park, Jeong, Park, Shin, Kim, Lee (bib23) 2007; 12
Song, Cheong, Jo, Choi, Noh, Heo (bib14) 2009; 37
Kee, Park, Lee, Kwon, Pyo, Western Dialysis Physical Association (bib12) 2012; 65
Bonten, Slaughter, Ambergen, Hayden, van Voorhis, Nathan (bib6) 1998; 158
Efe Iris, Sayıner, Yildirmak, Simsek, Arat (bib11) 2013; 41
Weber, Huang, Oriola, Huskins, Noskin, Harriman (bib20) 2007; 28
Martone (bib2) 1998; 19
Matar, Tarrand, Raad, Rolston (bib10) 2006; 34
Digiovine, Chenoweth, Watts, Higgins (bib16) 1999; 160
Streit, Jones, Sader, Fritsche (bib3) 2004; 24
Hayden, Blom, Lyle, Moore, Weinstein (bib18) 2008; 29
Uttley, Collins, Naidoo, George (bib1) 1988; 1
Byun, Kang (bib7) 2013; 43
Murray (bib5) 2000; 342
Sohn, Peck, Joo, Ha, Kang, Chung (bib17) 2013; 17
Cheong, Song, Eom, Kim, Choi, Choi (bib4) 2002; 34
Matar (10.1016/j.ajic.2014.06.024_bib10) 2006; 34
Song (10.1016/j.ajic.2014.06.024_bib14) 2009; 37
Parsons (10.1016/j.ajic.2014.06.024_bib8) 2000
Weber (10.1016/j.ajic.2014.06.024_bib20) 2007; 28
Streit (10.1016/j.ajic.2014.06.024_bib3) 2004; 24
Park (10.1016/j.ajic.2014.06.024_bib23) 2007; 12
Sohn (10.1016/j.ajic.2014.06.024_bib17) 2013; 17
Byun (10.1016/j.ajic.2014.06.024_bib7) 2013; 43
Efe Iris (10.1016/j.ajic.2014.06.024_bib11) 2013; 41
Kim (10.1016/j.ajic.2014.06.024_bib13) 2012; 40
Cheong (10.1016/j.ajic.2014.06.024_bib4) 2002; 34
Murray (10.1016/j.ajic.2014.06.024_bib5) 2000; 342
Digiovine (10.1016/j.ajic.2014.06.024_bib16) 1999; 160
Duckro (10.1016/j.ajic.2014.06.024_bib21) 2005; 165
Martone (10.1016/j.ajic.2014.06.024_bib2) 1998; 19
Kee (10.1016/j.ajic.2014.06.024_bib12) 2012; 65
Uttley (10.1016/j.ajic.2014.06.024_bib1) 1988; 1
Greenland (10.1016/j.ajic.2014.06.024_bib9) 1993; 49
Muto (10.1016/j.ajic.2014.06.024_bib19) 2003; 24
Huskins (10.1016/j.ajic.2014.06.024_bib22) 2011; 364
Bonten (10.1016/j.ajic.2014.06.024_bib6) 1998; 158
Carmeli (10.1016/j.ajic.2014.06.024_bib15) 2002; 162
Hayden (10.1016/j.ajic.2014.06.024_bib18) 2008; 29
References_xml – volume: 165
  start-page: 302
  year: 2005
  end-page: 307
  ident: bib21
  article-title: Transfer of vancomycin-resistant enterococci via health care worker hands
  publication-title: Arch Intern Med
– volume: 19
  start-page: 539
  year: 1998
  end-page: 545
  ident: bib2
  article-title: Spread of vancomycin-resistant enterococci: why did it happen in the United States?
  publication-title: Infect Control Hosp Epidemiol
– volume: 1
  start-page: 57
  year: 1988
  end-page: 58
  ident: bib1
  article-title: Vancomycin-resistant enterococci
  publication-title: Lancet
– volume: 24
  start-page: 111
  year: 2004
  end-page: 118
  ident: bib3
  article-title: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
  publication-title: Int J Antimicrob Agents
– volume: 43
  start-page: 287
  year: 2013
  end-page: 295
  ident: bib7
  article-title: Risk factors and clinical outcomes for vancomycin-resistant Enterococcus colonization on intensive care unit admission [Korean]
  publication-title: J Korean Acad Nurs
– start-page: 214
  year: 2000
  end-page: 226
  ident: bib8
  article-title: Using SAS® software to perform a case control match on propensity score in an observational study
– volume: 162
  start-page: 2223
  year: 2002
  end-page: 2228
  ident: bib15
  article-title: Health and economic outcomes of vancomycin-resistant enterococci
  publication-title: Arch Intern Med
– volume: 160
  start-page: 976
  year: 1999
  end-page: 981
  ident: bib16
  article-title: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit
  publication-title: Am J Respir Crit Care Med
– volume: 17
  start-page: e240
  year: 2013
  end-page: e246
  ident: bib17
  article-title: Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital
  publication-title: Int J Infect Dis
– volume: 37
  start-page: 734
  year: 2009
  end-page: 740
  ident: bib14
  article-title: Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis
  publication-title: Am J Infect Control
– volume: 65
  start-page: 57
  year: 2012
  end-page: 60
  ident: bib12
  article-title: Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis
  publication-title: Jpn J Infect Dis
– volume: 29
  start-page: 149
  year: 2008
  end-page: 154
  ident: bib18
  article-title: Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment
  publication-title: Infect Control Hosp Epidemiol
– volume: 34
  start-page: 276
  year: 2002
  end-page: 284
  ident: bib4
  article-title: Colonization rate, risk factor for acquisition, and genetic diversity of vancomycin-resistant enterococci (VRE) isolated from rectal culture of patients in intensive care units from ten large hospitals in Korea
  publication-title: Korean J Infect Dis
– volume: 41
  start-page: 261
  year: 2013
  end-page: 262
  ident: bib11
  article-title: Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors
  publication-title: Am J Infect Control
– volume: 342
  start-page: 710
  year: 2000
  end-page: 721
  ident: bib5
  article-title: Vancomycin-resistant enterococcal infections
  publication-title: New Engl J Med
– volume: 34
  start-page: 534
  year: 2006
  end-page: 536
  ident: bib10
  article-title: Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer
  publication-title: Am J Infect Control
– volume: 49
  start-page: 865
  year: 1993
  end-page: 872
  ident: bib9
  article-title: Maximum likelihood estimation of the attributable fraction from logistic models
  publication-title: Biometrics
– volume: 24
  start-page: 362
  year: 2003
  end-page: 386
  ident: bib19
  article-title: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus
  publication-title: Infect Control Hosp Epidemiol
– volume: 158
  start-page: 1127
  year: 1998
  end-page: 1132
  ident: bib6
  article-title: The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable
  publication-title: Arch Intern Med
– volume: 40
  start-page: 1018
  year: 2012
  end-page: 1019
  ident: bib13
  article-title: Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission
  publication-title: Am J Infect Control
– volume: 28
  start-page: 249
  year: 2007
  end-page: 260
  ident: bib20
  article-title: Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force
  publication-title: Infect Control Hosp Epidemiol
– volume: 12
  start-page: 112
  year: 2007
  end-page: 121
  ident: bib23
  article-title: Survey on the infection control of multidrug-resistant microorganisms in general hospitals in Korea
  publication-title: Korean J Nosocomial Infect Control
– volume: 364
  start-page: 1407
  year: 2011
  end-page: 1418
  ident: bib22
  article-title: Intervention to reduce transmission of resistant bacteria in intensive care
  publication-title: N Engl J Med
– volume: 165
  start-page: 302
  year: 2005
  ident: 10.1016/j.ajic.2014.06.024_bib21
  article-title: Transfer of vancomycin-resistant enterococci via health care worker hands
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.3.302
– volume: 34
  start-page: 276
  year: 2002
  ident: 10.1016/j.ajic.2014.06.024_bib4
  article-title: Colonization rate, risk factor for acquisition, and genetic diversity of vancomycin-resistant enterococci (VRE) isolated from rectal culture of patients in intensive care units from ten large hospitals in Korea
  publication-title: Korean J Infect Dis
– volume: 342
  start-page: 710
  year: 2000
  ident: 10.1016/j.ajic.2014.06.024_bib5
  article-title: Vancomycin-resistant enterococcal infections
  publication-title: New Engl J Med
  doi: 10.1056/NEJM200003093421007
– volume: 65
  start-page: 57
  year: 2012
  ident: 10.1016/j.ajic.2014.06.024_bib12
  article-title: Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.65.57
– volume: 19
  start-page: 539
  year: 1998
  ident: 10.1016/j.ajic.2014.06.024_bib2
  article-title: Spread of vancomycin-resistant enterococci: why did it happen in the United States?
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.2307/30141777
– volume: 1
  start-page: 57
  year: 1988
  ident: 10.1016/j.ajic.2014.06.024_bib1
  article-title: Vancomycin-resistant enterococci
  publication-title: Lancet
  doi: 10.1016/S0140-6736(88)91037-9
– start-page: 214
  year: 2000
  ident: 10.1016/j.ajic.2014.06.024_bib8
– volume: 364
  start-page: 1407
  year: 2011
  ident: 10.1016/j.ajic.2014.06.024_bib22
  article-title: Intervention to reduce transmission of resistant bacteria in intensive care
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1000373
– volume: 12
  start-page: 112
  year: 2007
  ident: 10.1016/j.ajic.2014.06.024_bib23
  article-title: Survey on the infection control of multidrug-resistant microorganisms in general hospitals in Korea
  publication-title: Korean J Nosocomial Infect Control
– volume: 34
  start-page: 534
  year: 2006
  ident: 10.1016/j.ajic.2014.06.024_bib10
  article-title: Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2006.04.205
– volume: 162
  start-page: 2223
  year: 2002
  ident: 10.1016/j.ajic.2014.06.024_bib15
  article-title: Health and economic outcomes of vancomycin-resistant enterococci
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.162.19.2223
– volume: 158
  start-page: 1127
  year: 1998
  ident: 10.1016/j.ajic.2014.06.024_bib6
  article-title: The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.158.10.1127
– volume: 40
  start-page: 1018
  year: 2012
  ident: 10.1016/j.ajic.2014.06.024_bib13
  article-title: Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2012.01.009
– volume: 24
  start-page: 111
  year: 2004
  ident: 10.1016/j.ajic.2014.06.024_bib3
  article-title: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2003.12.019
– volume: 41
  start-page: 261
  year: 2013
  ident: 10.1016/j.ajic.2014.06.024_bib11
  article-title: Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2012.04.331
– volume: 160
  start-page: 976
  year: 1999
  ident: 10.1016/j.ajic.2014.06.024_bib16
  article-title: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.160.3.9808145
– volume: 37
  start-page: 734
  year: 2009
  ident: 10.1016/j.ajic.2014.06.024_bib14
  article-title: Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2008.09.025
– volume: 43
  start-page: 287
  year: 2013
  ident: 10.1016/j.ajic.2014.06.024_bib7
  article-title: Risk factors and clinical outcomes for vancomycin-resistant Enterococcus colonization on intensive care unit admission [Korean]
  publication-title: J Korean Acad Nurs
  doi: 10.4040/jkan.2013.43.2.287
– volume: 17
  start-page: e240
  year: 2013
  ident: 10.1016/j.ajic.2014.06.024_bib17
  article-title: Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2012.09.019
– volume: 24
  start-page: 362
  year: 2003
  ident: 10.1016/j.ajic.2014.06.024_bib19
  article-title: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/502213
– volume: 28
  start-page: 249
  year: 2007
  ident: 10.1016/j.ajic.2014.06.024_bib20
  article-title: Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/512261
– volume: 49
  start-page: 865
  year: 1993
  ident: 10.1016/j.ajic.2014.06.024_bib9
  article-title: Maximum likelihood estimation of the attributable fraction from logistic models
  publication-title: Biometrics
  doi: 10.2307/2532206
– volume: 29
  start-page: 149
  year: 2008
  ident: 10.1016/j.ajic.2014.06.024_bib18
  article-title: Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/524331
SSID ssj0009365
Score 2.2780836
Snippet The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors affecting...
Background The clinical and economic impact of vancomycin-resistant Enterococcus (VRE) colonization remains unclear. Little data are available on factors...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1062
SubjectTerms Biological and medical sciences
Clinical outcomes
Cohort Studies
Comparative analysis
Economic impact
Enterococcus
Enterococcus - drug effects
Enterococcus - isolation & purification
Epidemiology. Vaccinations
Female
General aspects
Gram-Positive Bacterial Infections - economics
Gram-Positive Bacterial Infections - epidemiology
Gram-Positive Bacterial Infections - mortality
Health Care Costs
Hospitalization
Humans
Infection Control
Infectious Disease
Infectious diseases
Intensive care
Intensive Care Units
Length of Stay
Male
Medical sciences
Middle Aged
Mortality
Nosocomial infections
Retrospective Studies
Survival Analysis
Treatment Outcome
Vancomycin Resistance
Title Vancomycin-resistant Enterococcus colonization in the intensive care unit: Clinical outcomes and attributable costs of hospitalization
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0196655314009390
https://www.clinicalkey.es/playcontent/1-s2.0-S0196655314009390
https://dx.doi.org/10.1016/j.ajic.2014.06.024
https://www.ncbi.nlm.nih.gov/pubmed/25278394
https://www.proquest.com/docview/1611651549
https://www.proquest.com/docview/1586105213
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqckGqEG8CZWUkbijsOn4k4VZVVAtIvUBRb5YfiUjVJiuSHLhw5HczEzu7qqBF4rhZe-K1Z8bj9TffEPLaM8fryhRp5cDIRaFYapzFW_acZcrxQrkJbXGq1mfi47k83yPHcy4Mwiqj7w8-ffLW8ckyzuZy0zTLz8jsoiTokMBjeYnndmSvA51--3MH8yi5CjDGUqXYOibOBIyXuWiQxpCJicMzEzdtTgcb08OU1aHWxc3B6LQpndwn92I0SY_CgB-Qvap9SA7CX3E0ZBg9Ir--grzu6odr2hQO1xgwtgOd0AAduEM39hSpq-eMTNq0FKJC2szgdoroMDqC7b-jkUb0knbjADKrnprWUzOEulmYhgWy-qGnXU2_xZIkUe5jcnby_svxOo3lF1Ins9WQ8mJVu1waL633BeMImPEGTq_WC65ybpTNpVfKW1vbgptSWCVWFURMwpcmY_wJ2W-7tnpGqBeslJmVzOTQRJZWmdzjBaHyGXfeJ4TN865d5CbHEhmXegahXWhcK41rpRGJl4mEvNn22QRmjltb83k59ZxzCl5Sw8Zxa6_8b72qPhp6r5nuM73SfyhjQuS25zV9_ucbF9d0bfvTsqIoVFGyhBzOyqd3o1DIooRsewl5tf0aHAXe_pi26kZoI8EQMVWbJ-RpUNqdcIkFV0rx_D9H_YLcxU8B5HhI9ofvY_USgrXBLiZrXJA7Rx8-rU9_A3WjPuY
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaq7QGkCvEmUIqRuKFo1_EjDreqotrSshda1JvlRyJSlWRFkgN_gN-NJ3Z2VUGLxDXxTLz2eDxef_MNQu8csbQqtUxL6xc5k4Kk2hq4Zc9JJiyVwo5oi5VYXrBPl_xyBx1NuTAAq4y-P_j00VvHJ_M4mvN1Xc-_ALOL4N6GGBzLC39u3wV2KjZDu4cnp8vVlnuXioBkLEQKAjF3JsC89FUNTIaEjTSeGbttf9pb686PWhXKXdwej4770vFD9CAGlPgw9PkR2imbx2gv_BuHQ5LRE_Trq9fXfv9p6yb152uIGZsej4CA1ntEO3QY2KunpExcN9gHhrie8O0YAGJ48Mv_A45Mote4HXqvs-ywbhzWfSidBZlYXlfXd7it8LdYlSTqfYoujj-eHy3TWIEhtTxb9CmVi8rmXDtunJOEAmbGaX-ANY5RkVMtTM6dEM6YykiqC2YEW5Q-aGKu0Bmhz9CsaZvyBcKOkYJnhhOd-ya8MELnDu4IhcuodS5BZBp3ZSM9OVTJuFYTDu1KwVwpmCsFYLyMJej9RmYdyDnubE2n6VRT2ql3lMrvHXdK5X-TKru41jtFVJephfrDHhPEN5I3TPqfXzy4YWubn5ZJKYUsSIL2J-NT214IIFICwr0Evd289r4CLoB0U7aDb8P9WoRsbZqg58Fot8o51Fwp2Mv_7PUbdG95_vlMnZ2sTl-h-_AmYB730az_MZSvfezWm4O4Nn8DP99Blw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vancomycin-resistant+Enterococcus+colonization+in+the+intensive+care+unit%3A+clinical+outcomes+and+attributable+costs+of+hospitalization&rft.jtitle=American+journal+of+infection+control&rft.au=Jung%2C+Euihan&rft.au=Byun%2C+Sookjin&rft.au=Lee%2C+Hojin&rft.au=Moon%2C+Sang+Yi&rft.date=2014-10-01&rft.eissn=1527-3296&rft.volume=42&rft.issue=10&rft.spage=1062&rft_id=info:doi/10.1016%2Fj.ajic.2014.06.024&rft_id=info%3Apmid%2F25278394&rft.externalDocID=25278394
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01966553%2FS0196655314X00106%2Fcov150h.gif